Merit Medical Systems, Inc. (MMSI) Institutional Ownership & Insider Trading

403 institutions reported holding Merit Medical Systems, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 13 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MMSIMerit Medical Systems, Inc.Follow MMSI — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 5.6B
P/E TTM: 38.4
Dividend yield: —
52-week: —
Next earnings: 29 Oct, in 4 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

403 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +4.3%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	403	63	+4.3%	174	50	115	47
Mar 26	397	59	-5.5%	151	52	118	44
Dec 25	386	64	+1.4%	160	41	102	34
Sep 25	370	61	-2.6%	125	34	123	35
Jun 25	371	63	-1.4%	122	35	119	44
Mar 25	370	62	+3.9%	129	38	119	40
Dec 24	375	61	+1.4%	133	42	94	39
Sep 24	371	59	-3.8%	114	68	101	18

Merit Medical Systems, Inc. — questions

Who owns Merit Medical Systems, Inc. stock?: 403 institutions reported Merit Medical Systems, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (15.8%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.8%), VANGUARD CAPITAL MANAGEMENT LLC (4.3%).
Are Merit Medical Systems, Inc. insiders buying or selling?: 13 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Merit Medical Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.